跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
THE-349
首页
药物
THE-349
THE-349
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US 7230109 B2
申请人: SMITHKLINE BEECHAM PLC
优先权: 2002
US
5 件公开
IdeZ VARIANT
EP 4772624 A1
申请人: ASTELLAS PHARMA INC
优先权: 2023
CN
EP
WO
3 件公开
Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device
US 2014131686 A1
申请人: SEMICONDUCTOR ENERGY LAB
优先权: 2012
CN
US
2 件公开
Use of enterococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver
US 2007059292 A1
申请人: BAKULIN IGOR G
优先权: 2003
US
Soluble rubella E1 envelope protein variants
US 2007154883 A1
申请人: UPMEIER BARBARA
优先权: 2005
US
NOVEL ADAMTS-13 MUTANT
US 2012064057 A1
申请人: SOEJIMA KENJI
优先权: 2007
US
Tyrosine Phosphorylation Sites
US 2010129929 A1
申请人: POLAKEWICZ ROBERTO
优先权: 2007
US
Ultraconserved regions encoding ncRNAs
EP 2650383 A1
申请人: UNIV OHIO STATE RES FOUND
优先权: 2007
EP
Pharmaceutical composition with effects of clearing throat, reducing swelling and alleviating pain
CN 101721614 B
申请人: JILIN AODONG YANBIAN PHARMACEUTICAL CO LTD
优先权: 2009
CN
Rotavirus-resistant drug acting target, building method and application method thereof
CN 101863966 B
申请人: UNIV PLA 3RD MILITARY MEDICAL
优先权: 2010
CN
第 1 / 2 页
上一页
下一页
药物
反馈